The MALAT1–α-synuclein axis was also a target of two neuroprotective substances: beta-asarone, an epilepsy treatment, and resveratrol, a natural substance that is known for its protective effect against neurological damage caused in AD, PD, and ischemic stroke [35,36]. This evidence concerns the gene SNCA and Parkinson disease.